PIP5K1A Antikörper (N-Term)
-
- Target Alle PIP5K1A Antikörper anzeigen
- PIP5K1A (Phosphatidylinositol-4-Phosphate 5-Kinase, Type I, alpha (PIP5K1A))
-
Bindungsspezifität
- N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser PIP5K1A Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Enzyme Immunoassay (EIA)
- Spezifität
- This antibody reacts to PIP5K1A.
- Aufreinigung
- Protein G column, eluted with high and low pH buffers and neutralized immediately, followed by dialysis against PBS
- Immunogen
- This antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide selected from the N-terminal region of human PIP5K1A.
- Isotyp
- Ig Fraction
- Top Product
- Discover our top product PIP5K1A Primärantikörper
-
-
- Applikationshinweise
-
ELISA: 1/1,000. Western blotting: 1/100 - 1/500.
Other applications not tested.
Optimal dilutions are dependent on conditions and should be determined by the user. - Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Konzentration
- 0.25 mg/mL
- Buffer
- PBS with 0.09 % (W/V) sodium azide
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handhabung
- Avoid repeated freezing and thawing.
- Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store the antibody undiluted at 2-8 °C for one month or (in aliquots) at-20 °C for longer.
-
- Target
- PIP5K1A (Phosphatidylinositol-4-Phosphate 5-Kinase, Type I, alpha (PIP5K1A))
- Andere Bezeichnung
- PIP5K1A (PIP5K1A Produkte)
- Synonyme
- Pip5k1b antikoerper, pip5k1c antikoerper, PIP5K1A antikoerper, pip5k1b antikoerper, Pipk5a antikoerper, Pipk5b antikoerper, pip5k1a antikoerper, zgc:110576 antikoerper, im:7140933 antikoerper, zgc:158838 antikoerper, phosphatidylinositol-4-phosphate 5-kinase type 1 alpha antikoerper, phosphatidylinositol-4-phosphate 5-kinase, type 1, alpha antikoerper, phosphatidylinositol-4-phosphate 5-kinase, type I, alpha L homeolog antikoerper, phosphatidylinositol-4-phosphate 5-kinase, type I, alpha antikoerper, phosphatidylinositol-4-phosphate 5-kinase, type 1 alpha antikoerper, phosphatidylinositol-4-phosphate 5-kinase, type I, alpha, a antikoerper, phosphatidylinositol-4-phosphate 5-kinase, type I, alpha, b antikoerper, PIP5K1A antikoerper, Pip5k1a antikoerper, pip5k1a.L antikoerper, pip5k1a antikoerper, pip5k1aa antikoerper, pip5k1ab antikoerper
- Hintergrund
- Overexpression of phosphatidylinositol phosphate 5-kinase alpha (PIP5KIalpha), which synthesizes PIP2, suppresses apoptosis, whereas a kinase-deficient mutant does not. Protection by the wild-type PIP5KIalpha isaccompanied by decreases in the generation of activated caspases and of caspase 3-cleaved PARP. Protection is not mediated through PIP3 or Akt activation. An anti-apoptotic role for PIP(2) is substantiated by the finding that PIP5KIalpha is cleaved by caspase 3 during apoptosis, and cleavage inactivates PIP5KIalpha in vitro. Mutation of the P(4) position (D279A) of the PIP5KIalpha caspase 3 cleavage consensus prevents cleavage in vitro, and during apoptosis in vivo. Significantly, the caspase 3-resistant PIP5KIalpha mutant is more effective in suppressing apoptosis than the wild-type kinase. PIP2 is a direct regulator of apical and effector caspases in the death receptor and mitochondrial pathways, and PIP5KIalpha inactivation contributes to the progression of apoptosis.Synonyms: 68 kDa type I phosphatidylinositol-4-phosphate 5-kinase alpha, PIP5K1-alpha, PIP5KIalpha, Phosphatidylinositol-4-phosphate 5-kinase type-1 alpha, PtdIns(4)P-5-kinase 1 alpha
- Gen-ID
- 8394, 9606
- UniProt
- Q99755
- Pathways
- PI3K-Akt Signalweg, Mitotic G1-G1/S Phases, Inositol Metabolic Process, DNA Replication, Cell-Cell Junction Organization, Synthesis of DNA
-